Cargando…
Epigenetic suppression of PGC1α (PPARGC1A) causes collateral sensitivity to HMGCR-inhibitors within BRAF-treatment resistant melanomas
While targeted treatment against BRAF(V600E) improve survival for melanoma patients, many will see their cancer recur. Here we provide data indicating that epigenetic suppression of PGC1α defines an aggressive subset of chronic BRAF-inhibitor treated melanomas. A metabolism-centered pharmacological...
Autores principales: | Liang, Jiaxin, Yu, Deyang, Luo, Chi, Bennett, Christopher, Jedrychowski, Mark, Gygi, Steve P., Widlund, Hans R., Puigserver, Pere |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10241879/ https://www.ncbi.nlm.nih.gov/pubmed/37277330 http://dx.doi.org/10.1038/s41467-023-38968-7 |
Ejemplares similares
-
Cdc2-Like Kinase 2 Suppresses Hepatic Fatty Acid Oxidation and Ketogenesis Through Disruption of the PGC-1α and MED1 Complex
por: Tabata, Mitsuhisa, et al.
Publicado: (2014) -
Inhibition of the ER stress IRE1α inflammatory pathway protects against cell death in mitochondrial complex I mutant cells
por: Soustek, Meghan S., et al.
Publicado: (2018) -
Defective NADPH production in mitochondrial disease complex I causes inflammation and cell death
por: Balsa, Eduardo, et al.
Publicado: (2020) -
Engineered allele substitution at PPARGC1A rs8192678 alters human white adipocyte differentiation, lipogenesis, and PGC-1α content and turnover
por: Huang, Mi, et al.
Publicado: (2023) -
Relationship of PPARG, PPARGC1A, and PPARGC1B polymorphisms with susceptibility to hepatocellular carcinoma in an eastern Chinese Han population
por: Zhang, Sheng, et al.
Publicado: (2018)